Strong Quarterly Net Result
Net result of EUR 1.7 billion in Q1 2026, described as a pleasing start to the year and evidence of resilience across the group despite macro and geopolitical uncertainty.
Improved Reinvestment Yield and Diversified Investment Gains
Reinvestment yield improved to 4.2% in Q1, with positive revaluations in alternative investments and commodities demonstrating portfolio diversification benefits that partly offset negative fair value changes in fixed income and equities.
Life & Health Reinsurance Technical Strength
Life & Health Reinsurance delivered a total technical result of EUR 500 million (slightly above pro rata annual ambition); the Contractual Service Margin (CSM) increased due to solid business growth and favorable currency effects.
P&C Reinsurance Strong Underwriting Performance
P&C reinsurance posted a Q1 combined ratio of 66.8% benefiting from very low major losses; normalized combined ratio was 80.3%, aligned with full‑year guidance (~80%). Reserve releases totaled the expected 6 percentage points.
Global Specialty Insurance Outperformance
Global Specialty Insurance produced a pleasing Q1 result with a combined ratio of 83.7%, better than full‑year guidance, aided by benign loss experience and lower expenses.
ERGO: Promising Start and Solid Segment Results
ERGO delivered a net result of EUR 235 million in Q1 on the path to the 2026 target of EUR 0.9 billion. ERGO Germany reported a segment result of EUR 157 million; ERGO Germany P&C combined ratio was an excellent 86.7% (better than guidance).
Capital Strength Maintained
Solvency II ratio remained strong at 292% despite the full deduction of the new share buyback; the group reiterated capital return discipline (80%+ ambition) after returning 87% last year.
Outlook Intact for 2026 Net Result
2026 outlook unchanged with expected net result of EUR 6.3 billion; management believes the EUR 40 billion reinsurance revenue target remains within reach based on a healthy deal pipeline and anticipated deal closings later in the year.